Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS · Delayed Price · Currency is USD
0.2500
+0.0200 (8.70%)
Jan 2, 2026, 4:00 PM EST
Northwest Biotherapeutics Market Cap
Northwest Biotherapeutics has a market cap or net worth of $397.78 million as of January 5, 2026. Its market cap has increased by 7.86% in one year.
Market Cap
397.78M
Enterprise Value
483.67M
Revenue
937.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.25
Market Cap Chart
Since December 14, 2001, Northwest Biotherapeutics's market cap has increased from 10.29M to 397.78M, an increase of 3,765.97%. That is a compound annual growth rate of 16.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 397.78M | 11.43% |
| Dec 31, 2025 | 356.97M | -1.92% |
| Dec 31, 2024 | 363.95M | -55.71% |
| Dec 29, 2023 | 821.84M | -1.00% |
| Dec 30, 2022 | 830.10M | 25.14% |
| Dec 31, 2021 | 663.34M | -47.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 773.31M |
| Glass House Brands | 719.98M |
| Elite Pharmaceuticals | 537.20M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 342.98M |
| Silence Therapeutics | 290.49M |
| OpGen | 168.19M |